Biological Function of Hyperglycosylated hCG

Human Chorionic Gonadotropin (hCG)

Volumn , Issue , 2010, Pages 141-148

  Cole, Laurence A ^a  

^a USA hCG Reference Service   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882532943     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-384907-6.00013-X     Document Type: Chapter

References (49)

1. Cole LA, Dai D, Butler SA, Leslie KK, Kohorn EI Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG-regulated neoplasia. Gynecol Oncol 2006, 102:144-149.
2. Cole LA, Khanlian SA, Riley JM, Butler SA Hyperglycosylated hCG in gestational implantation and in choriocarcinoma and testicular germ cell malignancy tumorigenesis. J Reprod Med 2006, 51:919-929.
3. Cole LA, Butler SA Hyperglycosylated hCG and its free β-subunit, tumor markers and tumor promoters: a review. J Reprod Med 2008, 53:499-510.
4. Handshuh K, Guibourdenche J, Tsatsaris V, Guesnon M, Laurendeau I, Evain-Brion D, et al. Human chorionic gonadotropin produced by the invasive trophoblast but not the villous trophoblast promotes cell invasion and is down-regulated by peroxisome proliferator-activated receptor-a. Endocrinol 2007, 148:5011-5019.
5. Hamade AL, Nakabayashi K, Sato A, Kiyoshi K, Takamatsu Y, Laoag-Fernandez JB, et al. Transfection of antisense chorionic gonadotropin β gene into choriocarcinoma cells suppresses the cell proliferation and induces apoptosis. J Clin Endocrinol Metab 2005, 90:4873-4879.
6. Lei ZM, Taylor DD, Gercel-Taylor C, Rao CV Human chorionic gonadotropin promotes tumorigenesis of choriocarcinoma JAR cells. Troph Res 1999, 13:147-159.
7. Cole LA, Butler SA, Khanlian SA, Giddings A, Muller CY, Seckl MJ, et al. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia. Gynecol Oncol 2006, 102:151-159.
8. Cole LA, Khanlian SA, Sutton JM, Davies S, Stephens N Hyperglycosylated hCG (invasive trophoblast antigen, ITA): a key antigen for early pregnancy detection. Clin Biochem 2003, 36:647-655.
9. Kovalevskaya G, Genbacev O, Fisher SJ, Caceres E, O'Connor JF Trophoblast origin of hCG isoforms: cytotrophoblasts are the primary source of choriocarcinoma hCG. Mol Cell Endocrinol 2002, 194:147-155.
10. O'Connor JF, Ellish N, Kakuma T, Schlatterer J, Kovalevskaya G Differential urinary gonadotropin profiles in early pregnancy and early pregnancy loss. Prenat Diagn 1998, 18:1232-1240.
11. Sasaki Y, Ladner DG, Cole LA Hyperglycosylated hCG: the source of pregnancy failures. Fertil Steril 2008, 89:1781-1786.
12. Rechtman MP, Zhang J, Salamonsen LA Effect of inhibition of matrix metalloproteinases on endometrial decidualization and implantation in mated rats. J Reprod Fertil 1999, 117:169-177.
13. Sharkey ME, Adler RR, Nieder L, Brenner CA Matrix metalloproteinase expression during mouse peri-implantation development. Am J Reprod Immunol 1996, 36:72-80.
14. Nardo LG, Nikas G, Makrigiannakis A Molecules in blastocyst implantation: role of matrix metalloproteinases, cytokines and growth factors. J Reprod Med 2003, 48:137-147.
15. Qinglei L, Hongmei W, Yunge Z, Haiyan L, Qingxiang SA, Zhu C Identification and specific expression of matrix metalloproteinase-26 in rhesus monkey endometrium during early pregnancy. Mol Hum Reprod 2002, 8:934-940.
16. Bischof P, Campana A A model for implantation of the human blastocyst and early placentation. Hum Reprod Update 1996, 2:262-270.
17. Librach CL, Werb Z, Fitzgerald ML, Chiu K, Corwin NW, Esteves RA, et al. 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol 1991, 113:437-449.
18. Norwitz ER, Schust DJ, Fisher SJ Implantation and the survival of early pregnancy. N Engl J Med 2001, 345:1400-1408.
19. Lewis MP, Sullivan MH, Elder MG Regulation by interleukin-1 beta of growth and collagenase production by choriocarcinoma cells. Placenta 1994, 15:13-20.
20. Sekiya S, Oosaki T, Suzuki N, Takamizawa H Invasion potential of human choriocarcinoma cell lines and the role of lytic enzymes. Gynecol Oncol 1985, 22:324-333.
21. Chen Q, Stone P, McCowan L, Chamley L Interaction of Jar choriocarcinoma cells with endothelial cell monolayers. Placenta 2005, 26:617-625.
22. Maquoi E, Noël A, Foidart J Matrix metalloproteinases in choriocarcinoma cell lines: a potential regulatory role of extracellular matrix components. Placenta 1997, 18:123-142.
23. Okamoto T, Niu R, Yamada S, Osawa M Reduced expression of tissue inhibitor of metalloproteinase (TIMP)-2 in gestational trophoblastic disease. Mol Human Reprod 2002, 8:392-398.
24. Vegh GL, Tuncer ZS, Fulop V, Genest DR, Mok SC, Berkowitz RS Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta. Gynecol Oncol 1999, 75:248-253.
25. Schuster N, Krieglstein K Mechanisms of TGF-β-mediated apoptosis. Cell Tissue Res 2002, 307:1-14.
26. Kamijo T, Rajabi MR, Mizunuma H, Ibuki Y Biochemical evidence for autocrine/paracrine regulation of apoptosis in cultured uterine epithelial cells during mouse embryo implantation in vitro. Mol Human Reprod 1998, 4:990-998.
27. Pampferf S Apoptosis in rodent peri-implantation embryos: differential susceptibility of inner cell mass and trophectoderm cell lineages-A review. Placenta 2000, 21:S3-S10.
28. Shooner C, Caron PC, Fréchette-Frigon G, Leblanc V, Déry M-C, Asselin E TGF-beta expression during rat pregnancy and activity on decidual cell survival. Reprod Biol Endocrinol 2005, 3:20.
29. Liu Y-X, Gao F, Wei P, Chen X-L, Gao H-J, Zou R-Z, et al. Involvement of molecules related to angiogenesis, proteolysis and apoptosis in implantation in rhesus monkey and mouse. Contraception 2005, 71:249-262.
30. Knittel T, Mehde M, Kobold D, Saile B, Dinter C, Ramadori G Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver regulation by TNF-alpha and TGF-beta1. J Hepatol 1999, 30:48-60.
31. Murphy G, Reynolds JJ, Whitham SE, Docherty AJ, Angel P, Heath JK Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBOJ 1987, 6:1899-1904.
32. Qureshi HY, Sylvester J, El Mabrouk M, Zafarullah M TGF-beta-induced expression of tissue inhibitor of metalloproteinases-3 gene in chondrocytes is mediated by extracellular signal-regulated kinase pathway and Sp1 transcription factor. J Cell Physiol 2005, 203:345-352.
33. Stetler-Stevenson WG, Brown PD, Onisto M, Levy AT, Liotta LA Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 1990, 265:13933-13988.
34. Pringle K, Roberts C New light on early post-implantation pregnancy in the mouse: roles for insulin-like growth factor-II (IGF-II)?. Placenta 2007, 28:286-297.
35. Hwang JH, Koh SH, Han DI, Chung SR, Park MI, Hwang YY, et al. Expression of transforming growth factor-1, 2 in the decidua of the early pregnancy: comparison of decidua basalis and decidua parietalis. Korean J Obstet Gynecol 2001, 44:1145-1149.
36. Kingsley-Kallesen M, Johnson L, Scholtz B, Kelly D, Rizzino A Transcriptional regulation of the TGF-beta 2 gene in choriocarcinoma cells and breast carcinoma cells: differential utilization of cis-regulatory elements. In vitro Cell Dev Bio Anim 1997, 33:294-301.
37. Filla MS, Kaul KL Relative expression of epidermal growth factor receptor in placental cytotrophoblasts and choriocarcinoma cell lines. Placenta 1997, 18:17-27.
38. Lapthorn AJ, Harris DC, Littlejohn A, Lustbader JW, Canfield RE, Machin KJ, et al. Crystal structure of human chorionic gonadotropin. Nature 1994, 369:455-461.
39. Laub M, Jennissen HP Identification of the antihelix motif in the TGF-β superfamily by molecular 3D-rapid prototyping. Materialwissenschaft und Werkstofftechnik 2003, 34:1113-1119.
40. Lehnert SA, Akhurst RA Embryonic expression pattern of TGF beta type-1 RNA suggests both paracrine and autocrine mechanisms of action. Development 1988, 104:263-273.
41. Wu H, Lustbader JW, Liu Y, Canfield RE, Hendrickson WA Structure of human chorionic gonadotropin at 2.6Å resolution from MAD analysis of the selenomethionyl protein. Structure 1994, 2:545-548.
42. Isaacs NW Cystine knots. Curr Opin Struct Biol 1995, 5:391-395.
43. Khoo NK, Bechberger JF, Shepherd T, Bond SL, McCrae KR, Hamilton GS, et al. SV40 Tag transformation of the normal invasive trophoblast results in a premalignant phenotype I. Mechanisms responsible for hyperinvasiveness and resistance to anti-invasive action of TGFβ. Intl J Cancer 1998, 77:429-439.
44. Butler SA, Ikram MS, Mathieu S, Iles RK The increase in bladder carcinoma cell population induced by the free beta subunit of hCG is a result of an anti-apoptosis effect and not cell proliferation. Br J Cancer 2000, 82:1553-1556.
45. Delves PJ, Iles RK, Roitt IM, Lund T Designing a new generation of anti-hCG vaccines for cancer therapy. Mol Cell Endocrinol 2007, 260:276-281.
46. Carter WB, Sekharem M, Coppola D Human chorionic gonadotropin induces apoptosis in breast cancer. Breast Cancer Res Treat 2006, 100:S243-S244.
47. Butler SA, Iles RK Ectopic human chorionic gonadotropin β secretion by epithelial tumors and human chorionic gonadotropin β-induced apoptosis in Karposi's sarcoma: is there a connection?. Clin Cancer Res 2003, 9:4666-4673.
48. Iles RK Ectopic hCGβ expression by epithelial cancer: malignant behavior metastasis and inhibition of tumor cell apoptosis. Mol Cell Endorcinol 2007, 260:264-270.
49. Guibourdenche J, Handschuh K, Tstsaris V, Gerbaud P, Muller F, Evain Brion D, et al. Hyperglycosylated hCG is a marker of early human trophoblast invasion. J Clin Endocrinol Metab 2010, in press.